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anterior tibialis muscle, p < 0.05), cross section area of muscle fiber
(3,944 ± 536 vs. 3,066 ± 211 μm2, p < 0.05) and muscular protein
content (211 ± 10 mg/g vs. 151 ± 9 mg/g, p < 0.05), inhibited myotro-
pic markers expression (MuRF1 and MAFbx, p < 0.05), M1 macro-
phage infiltration (p < 0.05), muscular nitrotyrosine concentration
(229.4 ± 11 vs. 320 ± 43 pmol/mg, p < 0.05) and normalizedmyogenic
markers expression (MyoD1 and MHC, p < 0.05). Moreover, acute
thalidomide incubation in TNF-α pretreated C2C12 myoblasts
normalized the abnormal expressions of NFκBp65/iNOS, myotropic
and myogenic markers (p < 0.05). However, the in vitro beneficial
effects of thalidomide were reduced by concomitant pre-incubation
of amioguanidine.
Conclusions: By down-regulating of NFκBp65-iNOSpathway, chronic
thalidomide treatment decreased circulating CD16+ (inflammatory)
monocytes, inhibited muscular macrophage infiltration, suppressed
myotropic signals and normalized myogenic signals expression.
Taken together, thalidomide is a potential agent for treatment of
cirrhotic muscle wasting.
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Background and Aims: Catecholamines trigger proximal tubular
fluid retention and decrease Na+ and water delivery to the diluting
segment of the Henle’s loop, thereby reducing renal excretion of
solute-freewater. In advanced cirrhosis, non-osmotic hypersecretion
of vasopressin (ADH) has a role in causing dilutional hyponatremia,
but the advantage of ADHV2 receptor antagonists is still controversial
in the treatment of ascites. We meant to test the hypothesis that
adrenergic hyperfunctionmight greatly contribute towater retention
in experimental ascitic cirrhosis.
Methods: Hormonal status, renal function and tubular free-water
reabsorption (TFWR) were assessed in six groups of rats with ascitic
cirrhosis: rats with cirrhosis due to 13-week CCl4 administration
(group G1); cirrhotic rats receiving, from 11th to 13th weeks of CCl4,
daily diuretics alone (0.5 mg/kg furosemide plus 2 mg/kg K+-
canrenoate) (G2), or diuretics associated with guanfacine oral
prodrug (α2A adrenergic receptor agonist and sympatholytic agent)
2 (G3), 7 (G4), or 10 mg/kg (G5), or diuretics plus SSP-004240F1 (V2
receptor antagonist) 1 mg/kg (G6).
Results: Natriuresis was lower in G1 than in G2, G4 and G6 (all P <
0.05). Low-dose guanfacine, added to diuretics in G3, reduced serum
norepinephrine from 423 ± 22 (in G2) to 211 ± 41 ng/L (in G3) (P <
0.05), plasma renin activity from 35 ± 8 to 9 ± 2 ng/mL/h (G2 vs. G3)
(P < 0.05), and TFWR from45 ± 8 to 20 ± 6 microL/min (G2 vs. G3) (P <
0.01). Compared to G1 (untreated ascitic cirrhosis) or G2 (ascitic
cirrhosis treated with sole diuretics), TFWR was reduced to the same
extent in groups G3 (low-dose guanfacine plus diuretics) and G6 (V2
antagonist plus diuretics). TFWR correlated only with plasma
aldosterone (r = 0.51, P < 0.01) and urinary potassium excretion (r =
0.90, P < 0.001).
Conclusions: In ascitic cirrhosis, reduced volaemia with secondary
aldosteronism and adrenergic hyperfunction, especially when exa-
cerbated by potassium-depleting diuretics (furosemide), contributes
to tubular retention of water and dilutional hyponatremia. In this
case, suitable doses of sympatholytic agents are as effective as V2
antagonists when the aquaretic effect is needed.
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Background and Aims: Muscle wasting is a common feature in
cirrhosis. Our aim was to investigated main molecular pathways
contributing to muscle wasting in an experimental model of carbon
tetrachloride induced liver cirrhosis (CCl4).
Methods: 12-week old male wild-type (FVB) mice were used.
Cirrhosis was induced by intraperitoneal injection, twice a week, of
CCl4 for 12 weeks according to a well-established model. Control
animals received intraperitoneal injections of vehicle only (CTR).
Twelve weeks after body weight was recorded and mice were
sacrificed. Liver histological analysis was performed to confirm
cirrhosis. Peripheral muscles were rapidly dissected at the sacrifice
and weighed. Contractile properties of extensor digitorum longus
(EDL) was studied in vitro in both isometric and isotonic conditions.
Muscle samples were then rapidly stored for histological and
biological analysis. mRNA and proteins were quantified using real
time qRT-PCR and immunoblots.
Results: Results refer to fourteen mice, 7 CCl4 and 7 CTR. At the end
of 12 weeks, cirrhosis was histological confirmed in all the CCl4
treated mice. Compared with CTR, CCl4 mice had a reduction
in skeletal muscle weights, mainly in quadriceps and gastrocnemius.
The average cross sectional area (CSA) and The total myofiber
number of the quadriceps were significantly reduced in CCl4 vs CTR.
The frequency distribution of muscle fibers’ revealed a shift toward a
smaller size in CCl4 treated mice. Muscle atrophy was not associated
with a significant modification in muscles’ contractile properties.
Main molecular pathways involved in muscles atrophy were
subsequently investigated. Neither myostatin, AKT and mTOR
expressions was modified in CCL4 vs CTR. Upregulation of
proinflammatory citochines TNFα and IL6, mRNA and protein
expressions, were observed in CCl4 mice. Since TNF-alfa mediates
its effect on muscle by activation of NF-kB, we have also investigated
the expression of NFkB which was found to be significantly
increased in CCL4 mice. An upregulation of MuRF-1 expression
was also observed confirming activation of NF-κB-mediated gene
transcription.
Conclusions: Muscle atrophy is a characteristic complication in
experimentalmodels of CCl4 induced cirrhosis. NF-κB overexpression
in skeletal muscle is activated by inflammatory cytokines, particu-
larly tumor necrosis factor α (TNFα), suggesting that inflammation is
an important trigger ofmuscle atrophy in thismodel of liver cirrhosis.
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